News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Biogen (BIIB)'s Partner AC Immune SA Reels In $43.5 Million for Alzheimer's and Neurodegenerative Diseases R&D     5/10/2016
Anavex (AVXL)’s Alzheimer’s Drug a Possible Game Changer After Patients Reported Remarkable Positive Response     4/28/2016
A Day After The Pfizer (PFE)-Allergan (AGN) Deal Dies, Allergan Inks Potential $3.3 Billion Alzheimer’s Deal with Heptares     4/11/2016
AstraZeneca PLC (AZN), Eli Lilly (LLY) Alzheimer's Drug Enters Final Testing Stage, Astra Earns $100 Million     4/8/2016
TauRx Pharma Co-Founder's 30-Year Alzheimer's Quest May Bear Fruit in July     3/21/2016
Eli Lilly (LLY) Dropped After Primary Goal of Alzheimer's Study Was Changed     3/18/2016
Alzheon Wants Another Shot at Alzheimer's, Presents Data for Tweaked Phase III Studies on Once-Rejected Drug Tramiprosate     3/11/2016
As Pfizer (PFE) Kills Alzheimer's Trial, Axovant (AXON) Stock Plunges     2/3/2016
Denali, Helmed by Former Genentech (RHHBY) Execs, Takes Space in South San Francisco Site     1/20/2016
Pint-Sized Anavex (AVXL) May Soon Have the Data to Prove Biogen (BIIB) and Eli Lilly (LLY)'s Alzheimer's Approach is All Wrong     12/10/2015
Anavex (AVXL) May Have Just Become a Target for Biogen (BIIB) and Eli Lilly (LLY)     12/2/2015
Transition Therapeutics (TTH.TO)'s Alzheimer's Drug Effective in ELND005 Phase II/III Study     10/15/2015
TauRx Completes $135 Million Funding Round to Support Phase III Trials for Key Products     10/8/2015
30-Year-Old Hedge-Fund Whiz Kid’s Axovant (AXON) Starts Alzheimer’s Phase III Trial     10/7/2015
Nestle SA Advances Further into Medicine with Planned Alzheimer's Test     9/23/2015

News from Around the Web
Will A Common Heart Medication Help Treat Alzheimer’s Disease? Orebro University Study     5/26/2016
Alzheimer’s May Be Caused By Brain’s Sticky Defence Against Bugs, Harvard Study     5/26/2016
Loss Of Y Chromosome In Men Linked To Alzheimer's Disease, Uppsala Universitet Study     5/24/2016
Electronic Device Detects Molecules Linked To Cancer, Alzheimer's And Parkinson's, National Nanotechnology Laboratory Study     5/20/2016
Being Overbooked May Actually Be Good For Your Brain, University Of Texas At Dallas Study     5/18/2016
To Reduce Risk For Alzheimer's, Skip Lumosity And Get Onto The Yoga Mat, UCLA Study     5/11/2016
Bad Sense Of Direction May Be An Early Sign Of Alzheimer’s, Washington University in St. Louis Study Suggests     4/27/2016
Does A Person's Education Level Reduce The Risk Of Alzheimer's? Boston University Study     4/25/2016
Maple Syrup Protects Neurons And Nurtures Young Minds, University Of Montreal Hospital Research Centre Study     4/14/2016
Why People With Alzheimer's Stop Recognizing Their Loved Ones, Université de Montréal Study     4/11/2016
People With Low Body Temperature Have Worst Alzheimer's Symptoms, Universite Laval Study     4/8/2016
How To Transform Your Coffee Into A Wonder Drug     3/23/2016
Implantable Capsule Shows Promise For Alzheimer's Prevention, EPFL Study     3/21/2016
What Science Tells Us Can Affect Our Alzheimer's Disease Risk     3/18/2016
"Lost" Memories In Alzheimer Patients Can Be Found, MIT Study     3/18/2016

Press Releases
Cure Alzheimer’s Fund Release: New Study: ABeta Related To Innate Immunity, Raising New Questions About The Role Of Infection In Alzheimer's Disease     5/26/2016
Klogene Therapeutics, Inc. Awarded A $1.49 Million Grant For Alzheimer’s Disease Drug Development     5/17/2016
vTv Therapeutics Reports First Quarter Financial And Operational Results     5/13/2016
Accera, Inc. Completes Enrollment Of Phase 3 NOURISH AD Study Of AC-1204 For The Treatment Of Alzheimer's Disease     5/12/2016
Transition Therapeutics (TTH.TO) Announces Third Quarter Fiscal 2016 Financial Results     5/12/2016
Alzheimer's Drug Discovery Foundation Release: Ten New Grants Support Alzheimer's Drug Discovery And Biomarker Development     5/10/2016
ProMis Neurosciences Announces Identification Of A Fourth Novel Therapeutic Target For Alzheimer's Disease     5/5/2016
ORYZON Genomics Closes € 10.5 Million (12.1 M USD) Debt Financing     5/4/2016
Corium International, Inc. Announces Streamlined Bioequivalence Development Path For Transdermal Corplex Donepezil Following Positive Pre-IND Communication From FDA     5/3/2016
OLIGOMERIX Awarded A Grant For Its Alzheimer’s Drug Discovery Program Targeting Tau Oligomers From The NIH     5/2/2016
Fisher Center for Alzheimer's Research Foundation Scientists Discover Pathway That May Lead To Alzheimer's Disease     4/26/2016
Ortho Kinematics Secures CE Mark Approval To Support International Expansion     4/19/2016
Cantabio Pharmaceuticals Announces The Development Of Small Molecule Chaperones Of The Abeta Peptide For The Treatment Of Alzheimer's Disease In Collaboration With Novalix     4/13/2016
Axovant (AXON) To Present At The Goldman, Sachs & Co. Alzheimer's Symposium     4/5/2016
Probiodrug AG Announces Results Of Chronic Toxicology Studies With PQ912, Its "First In Class" Glutaminyl Cyclase (QC) Inhibitor For The Treatment Of Alzheimer’s Disease     4/4/2016